Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6562| Title: | Patterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in Australia | Authors: | Staatz, Christine E Martin, Neal Kong, David P Hollingworth, Samantha A |
Issue Date: | Mar-2018 | Source: | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018 | Journal Title: | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | Journal: | Digestive Liver Disease | DOI: | 10.1016/j.dld.2017.12.016 | metadata.dc.rights.holder: | Martin, N |
| Appears in Sites: | Gastroenterology and Hepatology, Princess Alexandra Hospital |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.